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After seminal research demonstrated the pulmonary veins
(PVs) and PV antrum contained substrates that can initiate
and perpetuate paroxysmal atrial ﬁbrillation (AF) in the
majority of patients,1–3 catheter ablation with circumferential
pulmonary vein isolation (PVI) has become the cornerstone
treatment for the management of paroxysmal AF.4 However,
in patients with persistent and long-standing persistent AF,
single- and multiple-procedure recurrence rates remain
high.5 Therefore, further ablation of left atrial and right atrial
lines, ablation of complex fractionated atrial electrograms
(CFAE), and, recently, the targeting of focal sources have
been performed, with mixed results.6–8
We report on the results of multiple catheter ablation
procedures in a patient with persistent AF, eventually
targeting 2 speciﬁc AF substrates within the left atrial
appendage (LAA) and coronary sinus (CS) after extensive
ablation, including circumferential isolation of the ipsilateral
PVs and superior vena cava (SVC), extensive CFAE ablation
within the left atrium (LA) and right atrium (RA), and
multiple linear lesions in both atria.KEYWORDS Atrial ﬁbrillation; Atrial tachyarrhythmia; Catheter ablation;
Left atrial appendage; Complex ablation
ABBREVIATIONS AE¼ atrial extrasystole; AF¼ atrial fibrillation; CFAE¼
complex fractionated atrial electrogram; CL ¼ cycle length; CS ¼
coronary sinus; CTI ¼ cavotricuspid isthmus; EPS ¼ electrophysiology
study; LA ¼ left atrium; LAA ¼ left atrial appendage; PV ¼ pulmonary
vein; PVI ¼ pulmonary vein isolation; RA ¼ right atrium; SR ¼ sinus
rhythm; SVC ¼ superior vena cava
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We present a case of a 37-year-old Syrian pilot, initially
referred to our institution for the management of sympto-
matic, drug-resistant, long-standing persistent AF of 5 years’
duration. He had failed medical therapy with ﬂecainide,
propafenone, sotalol, and amiodarone. In addition, he had
undergone several attempts at electrical cardioversion; how-
ever, AF recurred after only a short period of sinus rhythm
(SR). He had no other signiﬁcant medical history and he was
not obese. Blood pathology was essentially unremarkable,
with a normal thyroid function test. Transthoracic echocar-
diography revealed no evidence of left ventricular systolic or
diastolic dysfunction, no valvular dysfunction, and no
pulmonary hypertension. The LA size was 50 mm.
The initial electrophysiology study (EPS) was performed
under sedation with midazolam, sufentanil, and a continu-
ous infusion of propofol on October 18, 2010. Via femoral
venous access, an octapolar catheter was placed in the CS
and double transseptal punctures were performed using 8.5
French SL1 long sheaths (St Jude Medical, St Paul, MN)
and a transseptal needle. After both long sheaths were
advanced into the LA, a 3.5 mm irrigated-tip ablation
catheter was used in conjunction with a 3-dimensional
electroanatomic mapping system (CARTO; Biosense Web-
ster, Diamond Bar, CA) to reconstruct the LA. PV
angiography was performed to identify the PV ostia, which
were then marked on the LA map using tags. A 20 mm
spiral catheter was used to identify the PV potentials within
the PVs and ipsilateral wide circumferential lines were
ablated around the septal and lateral PVs. After all PVs
were isolated, the patient remained in AF and electrical
cardioversion (DCR) was attempted 3 times with re-
induction of AF following a few beats of SR. Through
use of the spiral catheter, the earliest activation during re-
induction was identiﬁed in the SVC; therefore isolation of
the SVC was performed. After SVC isolation, re-attempts at
DCR again resulted in re-initiation of AF, this time with
the earliest activation in the CS. Ablation was thenpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Catheter ablation for atrial ﬁbrillation (AF) is a
step-wise approach.
 Iatrogenic atrial arrhythmias can occur after AF
ablation.
 AF can be initiated from several different focal
sources, which may be unmasked only after
elimination of other sources.
 Elimination of sources that initiate AF can render
patients arrhythmia-free and improve quality
of life.
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as well as the CS until no further CFAEs were seen in these
areas. DCR was then repeated with conversion to and
maintenance of SR.
In-hospital Holter monitoring postprocedure showed
recurrent atrial tachyarrythmias. A second EPS was therefore
performed 2 days after the initial procedure. Access to the
LA was obtained as described above. During the second
procedure, no recovered PV conduction was seen, and an
atrial tachyarrhythmia was documented with a relatively
stable cycle length (CL) of 210–230 ms within the LAA
during AF. CFAE ablation was therefore performed at the
anterior wall of the LA near the LAA, at the area close to
the posterior and lateral mitral annulus, and ﬁnally within the
posterior CS, which led to conversion of AF to typical right
atrial ﬂutter with a CL of 240 ms. Therefore, ablation of a
cavotricuspid isthmus (CTI) line restored a stable SR. During
SR, the PVs were conﬁrmed isolated. Further ablation at the
CTI and the mitral isthmus resulted in bidirectional con-
duction block over both atrial isthmi.
Further monitoring showed recurrent atrial tachyarryth-
mias with predominantly AF and occasional AT 4 days after
the second procedure. Therefore, a third EPS was performed
6 days later. Three-dimensional mapping demonstrated no
areas with CFAE in the LA, RA, and CS except at the LA
anterior wall. Ablation at the LA anterior wall converted AF
to an AT with a stable CL of 270 ms and earliest activation at
the ridge and base of the LAA. Ablation at this region
resulted in stable SR. Pacing maneuvers were then per-
formed to demonstrate bidirectional block of the CTI and
mitral isthmus and no recovered PV conduction. LAA
isolation was not performed, as no further AFs/ATs were
inducible with burst pacing (shortest pacing CL = 240 ms)
with and without isoproterenol at the end of the ablation
procedure.
Postprocedural Holter monitoring showed only short epi-
sodes of paroxysmal AF, which was effectively suppressed with
sotalol. Therefore, the patient was medically treated with sotalol
80 mg 3 times a day and ﬂecainide 100 mg twice a day, and was
anticoagulated with warfarin on discharge. After 6 months ofmedical treatment and maintenance of stable SR after the
third ablation, all medications were ceased and recurrence
occurred. Holter monitoring demonstrated paroxysmal AF and
frequent atrial extrasystole (AE) with salvos. At this time,
transesophageal echocardiography was unremarkable, except
for a patent foramen ovale and potentially iatrogenic atrial septal
defect. Of note, the LA diameter had reduced to 45 mm.
The fourth ablation procedure was performed on June 10,
2011. During EPS, all PVs were still isolated. After extensive
ablation of CFAEs in the LA and RA, the LAA activation
recorded on a spiral catheter placed within the LAA became
relatively constant, with faster activity (CL 153 ms) com-
pared to the activation within the CS (Figure 1A). Pacing
within the LAA (CL 130 ms) resulted in AF termination and
the patient remained in a stable SR (Figure 1B). Therefore,
electrical isolation of the LAA was performed. Mapping
demonstrated a small gap at the mitral isthmus line, and
further ablation at this site led to completion of the LA
isthmus line and to LAA isolation (Figure 2A and B).
Afterwards, no further tachycardias were inducible with
and without isopreterenol.
Postprocedure monitoring for 2 days showed stable SR
with very frequent AEs, which degenerated into a short run
of AF during exercise. Therefore, a ﬁfth EPS was performed
3 days after the fourth ablation procedure. The LAA was
shown to be still isolated. Frequent AEs with very short
coupling intervals were observed, which became shorter with
intravenous isoproterenol infusion. These eventually degen-
erated into AF when the AE coupling interval shortened to
116 ms (Figure 3A) Using the 3.5-mm-tip ablation catheter,
the site of earliest atrial activation was identiﬁed within the
lateral CS (4 o’clock on the mitral annulus) (Figure 3B).
Focal ablation at this site with a maximum power output of
20 W eliminated the trigger (Figure 3C). At the end of the
procedure, no further AFs/ATs/AEs were inducible with
aggressive stimulation and isoproterenol infusion.
The patient was discharged on sotalol 80 mg daily and
warfarin. Sotalol was ceased 3 months after the last ablation.
Anticoagulation was continued owing to the LAA isolation.
During 3 years of regular follow-up with Holter monitoring,
no further atrial tachyarrythmias were documented.Discussion
In patients with persistent and long-standing persistent AF,
mechanisms that initiate and sustain AF remain undeﬁned in
individual patients. This is reﬂected in the single- and
multiple-procedure success rates of catheter ablation for the
management of AF.5,9 Because of this, additional techniques
have been employed to treat atrial tachyarrhythmias, such as
atrial lines and ablation of CFAEs, with variable results.6,7,10
In contrast to paroxysmal AF, the pathophysiology seems to
be different in persistent AF, with more involvement of the
whole atrium.6,11 This is seen during electroanatomic map-
ping, where diseased myocardium is represented by more
extensive areas of low voltage and fractionated potentials.
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Figure 1 Left atrial appendage (LAA) activity. A: Electrogram recordings demonstrating rapid ﬁring within the LAA, as seen by the lasso signals. B: Pacing
from within the LAA leads to termination of atrial ﬁbrillation.
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Figure 2 Left atrial appendage (LAA) isolation. A: Ablation at the posterior mitral isthmus leads to isolation of the LAA. B: Intracardiac electrograms
showing LAA isolation. The lasso is placed in the LAA, with 1:1 conduction during the ﬁrst 3 beats, then no further signal on the spiral catheter during sinus
rhythm (entrance block). Red tags¼ ablation points; white tags¼ pulmonary vein ostia; pink tags¼ fractionated potentials; yellow tag¼ point of isolation of the
LAA; AP ¼ anterior-posterior; PA ¼ posterior-anterior; RA ¼ right atrium; LA ¼ left atrium; CS ¼ coronary sinus.
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Figure 3 Ablation of focal atrial extrasystoles (AEs) that degenerated into atrial ﬁbrillation. A: Intracardiac electrograms showing recurrent AEs with earliest
activation at CS 1,2 (black arrows). Under isoproterenol infusion, the coupling interval became shorter, then degenerated into atrial ﬁbrillation. B: Intracardiac
electrograms showing a small, fragmented signal (red arrow) on the distal mapping catheter prior to ablation at the lateral coronary sinus. C: Three-dimensional
electroanatomic map of the right atrium, left atrium, and coronary sinus showing large areas of low voltage. Ablation at the lateral coronary sinus (red tags)
eliminated the frequent AEs.
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at the LA anterior wall resulted in conversion of AF to AT,
and eventual completion of the mitral isthmus line termi-
nated the tachycardia. During the fourth procedure, a clear
substrate with fast activation was demonstrated within the
LAA. This substrate was conﬁrmed when the atrial tachyar-
rhythmia was only able to be terminated with burst pacing
from within the LAA during ongoing AF that was refractory
to PVI and CFAE ablation in the LA during the initial 3
procedures. Interestingly, the AE focus from the CS was not
initially unmasked after LAA isolation and elimination of the
AF substrate, even with intravenous isoproterenol during the
fourth procedure. This AE substrate in the CS was seen only
during the ﬁfth procedure, which indicates that the AE
substrate had temporal variability. This strongly supports
multiple substrates for the perpetuation of AF in this patient.
Although extensive ablation in this patient led to the
identiﬁcation of several different sources of AF initiation
and perpetuation and the elimination of AF, as well as other
atrial tachyarrhythmias, one must assess the beneﬁts and risks
involved in undertaking such extensive ablation, particularly
in young patients. The risk of complications such as tampo-
nade and esophageal ﬁstulae may increase as the amount and
duration of lesions increase. In addition, the risk of develop-
ment of iatrogenic atrial tachyarrhythmias should be taken into
consideration after undergoing an extensive ablation strategy.
Generally, re-do procedures are postponed 2–3 months, and
this is the strategy undertaken in our center. However, in this
present case, the second and third redo procedures were
performed soon after the initial ablation secondary to the
identiﬁcation of a likely re-entrant AT. On the other hand,
such early re-do procedures may have provided the substrate
for the multiple complex atrial tachyarrhythmias that were
seen subsequently. Waiting out the 3-month blanking period
that is usually used post atrial tachyarrhthmia ablations before
considering re-do procedures rules out the acute effects of
catheter ablation and may reduce the amount of ablation
required. Additionally, optimizing medical and lifestyle
management plays an important role in the overall manage-
ment of patients with complex atrial arrhythmias. However, in
patients where focal sources can be identiﬁed and eliminated,
as with our patient during the fourth and ﬁfth procedures,
rendering patients arrhythmia-free can signiﬁcantly improve
quality of life and improve long-term atrial and LAA function.
Conclusion
We demonstrate that in persistent AF, substrates that initiate
and perpetuate atrial tachyarrhythmias can be identiﬁed inseveral left and right atrial structures. Isolation of these
structures can eliminate the substrates and lead to
maintenance of SR.References
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